Showing results (2031-2040 of 2,232) with videos related to
Sort By:
Pageof 224
Light, Science & Applications|January 22, 2024
A compact multi-pixel superconducting nanowire single-photon detector array supporting gigabit space-to-ground communicationsHao Hao, Qing-Yuan Zhao, Yang-Hui Huang, et al.JTO Clinical and Research Reports|September 16, 2024
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung AdenocarcinomaJia-Xin Lin, Kai Yin, Li-Xu Yan, et al.Future Oncology (London, England)|October 3, 2024
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancerBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.The New England Journal of Medicine|April 28, 2025
Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung CancerJohn V Heymach, Gerrina Ruiter, Myung-Ju Ahn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2024
Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN StudyBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.The Lancet. Respiratory Medicine|July 19, 2018
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trialZhijie Wang, Ying Cheng, Tongtong An, et al.Plos One|November 27, 2013
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteersAi-Hsiang Chou, Chia-Chyi Liu, Jui-Yuan Chang, et al.Translational Lung Cancer Research|September 29, 2021
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment optionsJiu-Wei Cui, Qing Zhou, Shun Lu, et al.Lung Cancer (Amsterdam, Netherlands)|September 13, 2025
Chinese expert consensus on perioperative management of patients with resectable anaplastic lymphoma kinase-fusion non-small cell lung cancerHai-Yan Tu, Chun Chen, Chang Chen, et al.Future Oncology (London, England)|June 12, 2023
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancerBenjamin J Solomon, Todd M Bauer, Tony S K Mok, et al.Pageof 224